# Treatment Outcome and Prognostic Factors for Rheumatoid Arthritis (RA) Patients With Interstitial Lung Disease (ILD)

> **NCT03099525** · — · UNKNOWN · sponsor: **Hanyang University** · enrollment: 600 (estimated)

## Conditions studied

- Rheumatoid Arthritis
- Interstitial Lung Disease

## Interventions

- **OTHER:** ILD

## Key facts

- **NCT ID:** NCT03099525
- **Lead sponsor:** Hanyang University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-10
- **Primary completion:** 2021-03
- **Final completion:** 2022-03
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2020-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03099525

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03099525, "Treatment Outcome and Prognostic Factors for Rheumatoid Arthritis (RA) Patients With Interstitial Lung Disease (ILD)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03099525. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*